3-(2-氟苯基)丙酸甲酯 | 143654-59-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-(2-氟苯基)丙酸甲酯
• 中文别名: 2-氟苯丙酸甲酯
• 英文名称: methyl 3-(2-fluorophenyl)propanoate
• CAS: 143654-59-5
• 化学式: C₁₀H₁₁FO₂
• mdl: MFCD12031751
• 分子量: 182.195
• InChiKey: LIXJACUBEJXGIC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2916399090
• 危险性防范说明：
  P264,P270,P301+P312,P330
• 危险性描述：
  H302,H315,H320,H335
• 储存条件：
  应存于室温、密封且干燥的环境中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 3-(2-fluorophenyl)propanoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 3-(2-fluorophenyl)propanoate
CAS number: 143654-59-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H11FO2
Molecular weight: 182.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-(2-氟苯基)丙酸甲酯 在 四氯化钛 三正丁胺 、 三氟甲磺酸三甲基硅酯 、 sodium methylate 、 三氯氧磷 作用下， 以 甲醇 、 乙醚 、 水 、 N,N-二甲基苯胺 、 甲苯 为溶剂， 生成 4-chloro-5-(2-fluoro-benzyl)-2-pyridin-2-yl-pyrimidine
  参考文献：
  名称：

  Novel Pyrimidine- And Triazine-Hepcidine Antagonists

  摘要：

  本发明涉及新的肝铁蛋白拮抗剂，包含它们的药物组合物以及将其用作药物的用途，特别是用于治疗铁代谢紊乱，如特别是铁缺乏病和贫血，特别是与慢性炎症性疾病相关的贫血（ACD：慢性疾病性贫血和AI：炎症性贫血）。

  公开号：

  US20120202806A1
• 作为产物：
  描述：

  (E)-3-(2-氟苯基)丙烯酸甲酯 在 甲醇 、 (4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(2-phenylpyridine(-1H))-iridium(III) hexafluorophosphate 、 二氢吡啶 作用下， 反应 16.0h， 以95%的产率得到3-(2-氟苯基)丙酸甲酯
  参考文献：
  名称：

  减少由光诱导氢原子转移引起的电子不足的烯烃

  摘要：

  氢原子从光氧化还原产生的Hantzsch酯自由基阳离子直接转移到缺电子的烯烃中，使得在温和，操作简单的条件下有效的正式加氢反应得以发展。HAT驱动的机制得到了实验和计算研究的支持。该反应适用于各种肉桂酸酯衍生物和相关结构，无论芳环中是否存在给电子或吸电子取代基且具有良好的官能团相容性。

  DOI：

  10.1002/adsc.202000751

文献信息

• Photodriven Transfer Hydrogenation of Olefins
  作者：Dasheng Leow、Ying-Ho Chen、Tzu-Hang Hung、Ying Su、Yi-Zhen Lin

  DOI：10.1002/ejoc.201403021

  日期：2014.11

  An improved practical method for the photodriven diimide reduction of olefins was investigated. This catalyst-free procedure proceeds at ambient temperature, utilizes air as oxidant and a lower hydrazine loading, and produces inert nitrogen gas as the sole byproduct. Several functional groups were tolerated, and in some cases, the reaction was chemoselective. Challenging substrates such as cinnamate

  研究了一种改进的用于烯烃的光驱动二酰亚胺还原的实用方法。这种无催化剂的过程在环境温度下进行，利用空气作为氧化剂和较低的肼负载，并产生惰性氮气作为唯一的副产品。几个官能团是可以容忍的，在某些情况下，反应是化学选择性的。具有挑战性的底物如肉桂酸酯衍生物和反式二苯乙烯以极好的产率减少。从家用紧凑型荧光灯泡发出的少量 UVA 射线被提议用于使二酰亚胺的顺式/反式异构化并促进氢从二酰亚胺中的损失。
• <i>meta</i> ‐Selective C−H Arylation of Fluoroarenes and Simple Arenes
  作者：Luo‐Yan Liu、Jennifer X. Qiao、Kap‐Sun Yeung、William R. Ewing、Jin‐Quan Yu

  DOI：10.1002/anie.202002865

  日期：2020.8.10

  to promote ortho‐C−H metalation. Based upon this reactivity, we employed an activated norbornene that traps the ortho‐palladation intermediate and is then relayed to the meta position, leading to meta‐selective C−H arylation of fluoroarenes. Deuterium experiment suggests that this meta‐arylation is initiated by ortho C−H activation and the catalytic cycle is terminated by C‐2 protonation. A dual‐ligand

  已知氟可促进邻位‐C−H 金属化。基于这种反应性，我们采用了一种活化的降冰片烯来捕获邻位钯化中间体，然后转移到间位，从而导致氟芳烃的间位选择性C−H 芳基化。氘实验表明，这种元芳基化是由邻位C-H 激活引发的，催化循环由 C-2 质子化终止。双配体系统对于观察到的高反应性和位点选择性至关重要。将这种方法应用于简单的苯或其他芳烃也可以提供具有良好收率和位点选择性的芳基化产物。
• C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
  申请人：The Procter & Gamble Co.

  公开号：US06410780B1

  公开（公告）日：2002-06-25

  The invention provides novel prostaglandin analogs. In particular, the present invention relates to compounds having a structure according to formula (I) wherein R1, R2, R3, R4, R5, R6, W, X, Z, a, b, p and q are defined below. This invention also includes optical isomers, diastereomers and enantiomers of formula (I), and pharmaceutically-acceptable salts, biohydrolyzable amides, esters, and imides thereof. The compounds of the present invention are useful for the treatment of a variety of diseases and conditions, such as bone disorders and glaucoma. Accordingly, the invention further provides pharmaceutical compositions comprising these compounds. The invention still further provides methods of treatment for bone disorders and glaucoma using these compounds or the compositions containing them.

  该发明提供了新型前列腺素类似物。具体来说，本发明涉及具有以下式(I)结构的化合物，其中R1、R2、R3、R4、R5、R6、W、X、Z、a、b、p和q如下所定义。本发明还包括式(I)的光学异构体、二对映异构体和对映异构体，以及其药用可接受盐、生物水解酰胺、酯和亚酰胺。本发明的化合物可用于治疗各种疾病和症状，如骨疾病和青光眼。因此，该发明进一步提供包含这些化合物的药物组合物。该发明还提供了使用这些化合物或含有它们的组合物治疗骨疾病和青光眼的方法。
• Synthesis and Inhibitory Studies of Phosphonic Acid Analogues of Homophenylalanine and Phenylalanine towards Alanyl Aminopeptidases
  作者：Weronika Wanat、Michał Talma、Błażej Dziuk、Paweł Kafarski

  DOI：10.3390/biom10091319

  日期：——

  henyl) propylphosphonic acid (compound 15c) being one of the best low-molecular inhibitors of both enzymes. To the best of our knowledge, P1 homophenylalanine analogues are the most active inhibitors of the APN among phosphonic and phosphinic derivatives described in the literature. Therefore, they constitute interesting building blocks for the further design of chemically more complex inhibitors.

  合成了新的高苯丙氨酸和苯丙氨酸膦酸类似物的文库，其苯环中含有氟和溴原子。评估了它们对人类（hAPN，CD13）和猪（pAPN）两种重要的丙氨酸氨基肽酶的抑制作用。酶学研究以及与文献数据的比较表明，高苯丙氨酸对苯丙氨酸衍生物的抑制作用较高。用1-氨基-3-（3-氟苯基）丙基膦酸（化合物15c）对hAPN的抑制常数在亚微摩尔范围内，对pAPN的抑制常数在微摩尔范围内。）是两种酶的最佳低分子抑制剂之一。据我们所知，P1高苯丙氨酸类似物是文献中描述的膦酸和次膦酸衍生物中APN活性最高的抑制剂。因此，它们构成了用于化学上更复杂的抑制剂的进一步设计的有趣的基础。基于分子模型模拟和SAR（结构-活性关系）分析，确定了hAPN和pAPN的酶抑制剂复合物的最佳结构。
• Aromatic C.sub.16 -C.sub.20 -substituted tetrahydro prostaglandins
  申请人：The Procter & Gamble Company

  公开号：US06107338A1

  公开（公告）日：2000-08-22

  The invention provides novel PGF analogs. In particular, the present invention relates to compounds having a structure according to the following formula: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, X, Y, and Z are defined below. This invention also includes optical isomers, diastereomers and enantiomers of the formula above, and pharmaceutically-acceptable salts, biohydrolyzable amides, esters, and imides thereof. The compounds of the present invention are useful for the treatment of a variety of diseases and conditions, such as bone disorders and glaucoma. Accordingly, the invention further provides pharmaceutical compositions comprising these compounds. The invention still further provides methods of treatment for bone disorders and glaucoma using theses compounds or the compositions containing them.

  本发明提供了新型PGF类似物。特别地，本发明涉及具有以下结构式的化合物：##STR1## 其中R.sub.1，R.sub.2，R.sub.3，R.sub.4，X，Y和Z的定义如下。本发明还包括上述公式的光学异构体、对映异构体和对映体，以及其药学上可接受的盐、生物可水解酰胺、酯和亚胺。本发明的化合物对于治疗各种疾病和病症，如骨疾和青光眼，有用。因此，本发明还提供包含这些化合物的药物组合物。本发明还提供使用这些化合物或含有它们的组合物治疗骨疾和青光眼的方法。